Tabernanthalog and ibogainalog inhibit the α7 and α9α10 nicotinic acetylcholine receptors via different mechanisms and with higher potency than the GABAA receptor and CaV2.2 channel is a research paper published in Biochemical Pharmacology (2024). On theSindex it has a DataRank of 0.345. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIGMS NIH HHS
Grant: R35 GM140947
National Institutes of Health
Grant: 5R35GM140947-05
GABAA receptors: function, physiology and involvement in anesthesia
Australian Research Council (ARC)
Grant: DP150103990
Discovery Projects - Grant ID: DP150103990
Australian Research Council
National Institute of General Medical Sciences
Washington University Taylor Family Institute for Innovative Psychiatric Research
Oklahoma State University Center for Health Sciences
FWCI
1.43
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals